Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act

Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act

ID: 39450

(Thomson Reuters ONE) -


BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE August 11, 2010 at 2.30 p.m.

Notification according to Chapter 2, Section 10 of the Finnish Securities Market
Act

Biotie Therapies Corp. ("Company") has gained knowledge of the notifications
regarding the following changes in holdings in accordance with Chapter 2,
Section 9 of the Finnish Securities Markets Act.

Pequot Capital Management, Inc (SEC-registration number 801-56015) address 187
Danbury Road, Wilton, CT 06897, United States of America ('Pequot') has notified
Company that as a result of share transactions carried out on 26 July, 2010
certain changes in holdings of the Company's shares have taken place between
various funds and trusts that are under Pequot's management.

As a result of these internal share transactions, the aggregate holdings of
Pequot remained unchanged. Though holdings by certain individual funds and
trusts changed, none of the holdings of the individual Funds did not reach,
exceed or fall below any shareholding disclosure threshold.

The changes in holdings in accordance with Chapter 2, Section 9 of the Finnish
Securities Markets Act of which the Company has gained knowledge are described
below.

Name of the Shares prior to the Shares after the % of shares after
shareholder transactions transactions the transactions

Pequot Healthcare 4,688,170 0 0
Fund, L.P.,
187 Danbury Road,
Wilton, CT 06897,
United States of
America;

Pequot Healthcare 3,686,577 0 0
Offshore Fund, Inc.,
Craigmuir Chambers,
c/o Harneys
Corporate Services
Limited, PO Box 71,
Road Town, Tortola,
British Virgin
Islands;

Pequot Diversified 751,000 0 0




Master Fund, Ltd.,
c/o Harneys
Corporate Services
Limited, Craigmuir
Chambers, PO Box
71, Road Town,
Tortola, British
Virgin Islands;

Pequot Healthcare 1,288,406 0 0
Institutional Fund,
L.P
187 Danbury Road,
Wilton, CT
06897,United States
of America;

Pequot Healthcare 2,040,770 0 0
Emerging Markets
Master Fund, Ltd.,
Walker House, c/o
Walker SPV Limited,
Mary Street, PO Box
908GT, George Town,
Grand Cayman, Cayman
Islands

Pequot Diversified 0 751,000 0.47%
Liquidating Trust,
c/o Wilmington Trust
Company, Rodney
Square North, 1100
North Market Street,
Wilmington, DE
19890, United States
of America

Pequot HC 0 4,688,170 2.95%
Liquidating Trust,
c/o Wilmington Trust
Company, Rodney
Square North, 1100
North Market Street,
Wilmington, DE
19890, United States
of America

Pequot HC EM 0 2,040,770 1.29%
Liquidating Trust,
c/o Wilmington Trust
Company, Rodney
Square North, 1100
North Market Street,
Wilmington, DE
19890, United States
of America

Pequot HC 0 1,288,406 0,81%
Institutional
Liquidating Trust,
c/o Wilmington Trust
Company, Rodney
Square North, 1100
North Market Street,
Wilmington, DE
19890, United States
of America

Pequot HC Offshore 0 3,686,577 2,32%
Liquidating Trust,
c/o Wilmington Trust
Company, Rodney
Square North, 1100
North Market Street,
Wilmington, DE
19890, United States
of America.

Total 12,454,923 12,454,923 7.85 %




The registered number of shares in Biotie Therapies Corp. is 158,752,560 and the
number of voting rights attached to the shares amounts to 158,752,560. Of these
shares 463.255 are owned by the Company.

Turku, August 11, 2010

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi(at)biotie.com

DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com



[HUG#1437166]








This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.

Source: Biotie Therapies Oyj via Thomson Reuters ONE


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Announcement of the 2nd quarter and 1st half 2010 interim results Outokumpu completes quarto plate investment in New Castle in the US
Bereitgestellt von Benutzer: hugin
Datum: 11.08.2010 - 13:30 Uhr
Sprache: Deutsch
News-ID 39450
Anzahl Zeichen: 0

contact information:
Town:

Turku



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 119 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act"
steht unter der journalistisch-redaktionellen Verantwortung von

Biotie Therapies Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Biotie: Selincro Launched in the United Kingdom ...

TURKU, FINLAND -- (Marketwired) -- 05/06/13 -- Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, B ...

Biotie: Selincro Launched in First European Markets ...

TURKU, FINLAND -- (Marketwired) -- 04/22/13 -- BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 22 April 2013 at 9:00 a.m.Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has started launching Selincro™ in the first European markets, ...

Alle Meldungen von Biotie Therapies Oyj



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z